101 related articles for article (PubMed ID: 16614101)
1. Interindividual variations in DNA adduct levels assessed by analysis of multiple genetic polymorphisms in smokers.
Ketelslegers HB; Gottschalk RW; Godschalk RW; Knaapen AM; van Schooten FJ; Vlietinck RF; Kleinjans JC; van Delft JH
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):624-9. PubMed ID: 16614101
[TBL] [Abstract][Full Text] [Related]
2. Benzo(a)pyrene diolepoxide (BPDE)-DNA adduct levels in leukocytes of smokers in relation to polymorphism of CYP1A1, GSTM1, GSTP1, GSTT1, and mEH.
Lodovici M; Luceri C; Guglielmi F; Bacci C; Akpan V; Fonnesu ML; Boddi V; Dolara P
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1342-8. PubMed ID: 15298956
[TBL] [Abstract][Full Text] [Related]
3. The use of 4-aminobiphenyl hemoglobin adducts and aromatic DNA adducts in lymphocytes of smokers as biomarkers of exposure.
Dallinga JW; Pachen DM; Wijnhoven SW; Breedijk A; van 't Veer L; Wigbout G; van Zandwijk N; Maas LM; van Agen E; Kleinjans JC; van Schooten FJ
Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):571-7. PubMed ID: 9681524
[TBL] [Abstract][Full Text] [Related]
4. GSTM1 null genotype as a risk factor for anti-BPDE-DNA adduct formation in mononuclear white blood cells of coke-oven workers.
Pavanello S; Siwinska E; Mielzynska D; Clonfero E
Mutat Res; 2004 Mar; 558(1-2):53-62. PubMed ID: 15036119
[TBL] [Abstract][Full Text] [Related]
5. Influence of glutathione S-transferase polymorphisms on genotoxic effects induced by tobacco smoke.
Palma S; Cornetta T; Padua L; Cozzi R; Appolloni M; Ievoli E; Testa A
Mutat Res; 2007 Sep; 633(1):1-12. PubMed ID: 17644396
[TBL] [Abstract][Full Text] [Related]
6. Comparison of DNA adduct levels in nasal mucosa, lymphocytes and bronchial mucosa of cigarette smokers and interaction with metabolic gene polymorphisms.
Peluso M; Neri M; Margarino G; Mereu C; Munnia A; Ceppi M; Buratti M; Felletti R; Stea F; Quaglia R; Puntoni R; Taioli E; Garte S; Bonassi S
Carcinogenesis; 2004 Dec; 25(12):2459-65. PubMed ID: 15319297
[TBL] [Abstract][Full Text] [Related]
7. DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay.
Gyorffy E; Anna L; Gyori Z; Segesdi J; Minárovits J; Soltész I; Kostic S; Csekeo A; Poirier MC; Schoket B
Carcinogenesis; 2004 Jul; 25(7):1201-9. PubMed ID: 15001535
[TBL] [Abstract][Full Text] [Related]
8. Body mass index modulates aromatic DNA adduct levels and their persistence in smokers.
Godschalk RW; Feldker DE; Borm PJ; Wouters EF; van Schooten FJ
Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):790-3. PubMed ID: 12163336
[TBL] [Abstract][Full Text] [Related]
9. Putative susceptibility markers of coronary artery disease: association between VDR genotype, smoking, and aromatic DNA adduct levels in human right atrial tissue.
Van Schooten FJ; Hirvonen A; Maas LM; De Mol BA; Kleinjans JC; Bell DA; Durrer JD
FASEB J; 1998 Oct; 12(13):1409-17. PubMed ID: 9761785
[TBL] [Abstract][Full Text] [Related]
10. Applicability of induced sputum for molecular dosimetry of exposure to inhalatory carcinogens: 32P-postlabeling of lipophilic DNA adducts in smokers and nonsmokers.
Besaratinia A; Maas LM; Van Breda SG; Curfs DM; Kleinjans JC; Wouters EF; Van Schooten FJ
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):367-72. PubMed ID: 10794480
[TBL] [Abstract][Full Text] [Related]
11. Myeloperoxidase (MPO) -463G->A reduces MPO activity and DNA adduct levels in bronchoalveolar lavages of smokers.
Van Schooten FJ; Boots AW; Knaapen AM; Godschalk RW; Maas LM; Borm PJ; Drent M; Jacobs JA
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):828-33. PubMed ID: 15159316
[TBL] [Abstract][Full Text] [Related]
12. hOGG1 Ser326Cys and XRCC1 Arg399Gln polymorphisms associated with chronic obstructive pulmonary disease.
Yang SF; Xu YJ; Xie JG; Zhang ZX
Chin Med J (Engl); 2009 Apr; 122(8):960-6. PubMed ID: 19493423
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of genetic damage in Brazilian footwear-workers: biomarkers of exposure, effect, and susceptibility.
Heuser VD; Erdtmann B; Kvitko K; Rohr P; da Silva J
Toxicology; 2007 Apr; 232(3):235-47. PubMed ID: 17292523
[TBL] [Abstract][Full Text] [Related]
14. DNA adducts and combinations of multiple lung cancer at-risk alleles in environmentally exposed and smoking subjects.
Peluso ME; Munnia A; Srivatanakul P; Jedpiyawongse A; Sangrajrang S; Ceppi M; Godschalk RW; van Schooten FJ; Boffetta P
Environ Mol Mutagen; 2013 Jul; 54(6):375-83. PubMed ID: 23797975
[TBL] [Abstract][Full Text] [Related]
15. Inherited susceptibility to bleomycin-induced micronuclei: correlating polymorphisms in GSTT1, GSTM1 and DNA repair genes with mutagen sensitivity.
Angelini S; Kumar R; Carbone F; Bermejo JL; Maffei F; Cantelli-Forti G; Hemminki K; Hrelia P
Mutat Res; 2008 Feb; 638(1-2):90-7. PubMed ID: 17953974
[TBL] [Abstract][Full Text] [Related]
16. 1,N2-propanodeoxyguanosine adducts: potential new biomarkers of smoking-induced DNA damage in human oral tissue.
Nath RG; Ocando JE; Guttenplan JB; Chung FL
Cancer Res; 1998 Feb; 58(4):581-4. PubMed ID: 9485001
[TBL] [Abstract][Full Text] [Related]
17. Association of DNA adducts and genotypes with birth weight.
Sram RJ; Binkova B; Dejmek J; Chvatalova I; Solansky I; Topinka J
Mutat Res; 2006 Sep; 608(2):121-8. PubMed ID: 16837240
[TBL] [Abstract][Full Text] [Related]
18. Determinants of the variability of aflatoxin-albumin adduct levels in Ghanaians.
Dash B; Afriyie-Gyawu E; Huebner HJ; Porter W; Wang JS; Jolly PE; Phillips TD
J Toxicol Environ Health A; 2007 Jan; 70(1):58-66. PubMed ID: 17162498
[TBL] [Abstract][Full Text] [Related]
19. Influence of DNA repair polymorphisms on biomarkers of genotoxic damage in peripheral lymphocytes of healthy subjects.
Zijno A; Verdina A; Galati R; Leopardi P; Marcon F; Andreoli C; Rossi S; Crebelli R
Mutat Res; 2006 Aug; 600(1-2):184-92. PubMed ID: 16824555
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of microsomal epoxide hydroxylase and glutathione S-transferases M1, T1 and P1, interactions with smoking, and risk for esophageal (Barrett) adenocarcinoma.
Casson AG; Zheng Z; Porter GA; Guernsey DL
Cancer Detect Prev; 2006; 30(5):423-31. PubMed ID: 17064856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
